Skip to article
Astra

Dermatology

Melasma

Manage melasma as a chronic, relapsing facial pigment disorder: confirm the clinical pattern, exclude inflammatory, drug-related, and dermal pigment mimics, identify hormonal and photic triggers, and use durable photoprotection with topical therapy before cautiously escalating refractory disease.

Clinical question: How should clinicians diagnose, treat, and safely escalate management of facial melasma?

Initial assessment

Confirm melasma clinically and identify presentations that need a different workup

The diagnosis is clinical; the pivotal decision is whether the pattern is truly melasma or a mimic.

Diagnose melasma when acquired, usually symmetric brown-to-gray macules or patches involve sun-exposed facial sites in a compatible setting. Record distribution and severity at baseline; MASI or modified MASI can standardize longitudinal assessment, while MELASQoL can identify clinically meaningful psychosocial burden that warrants more active management. PubMedMelasma - StatPearls - NCBI BookshelfPubMedA Scoping Review on Melasma Treatments and Their Histopathologic Correlates

Do not obtain routine laboratory studies for a typical presentation. Instead, take a directed history of pregnancy, oral contraceptive use, family history, ultraviolet and visible-light exposure, tanning exposure, facial inflammation, phototoxic medications or products, and prior topical corticosteroid use. Pregnancy, oral contraceptive use, female sex, family history, and light exposure are established associations or triggers. ScienceDirectBest practices in the treatment of melasma with a focus on patients with skin of color - ScienceDirectPubMedMelasma - StatPearls - NCBI BookshelfPubMedMelasma: A Step-by-Step Approach Towards a Multimodal Combination Therapy

Escalate diagnostic evaluation when pigmentation is asymmetric, sharply circumscribed, blue-gray rather than brown, temporally linked to dermatitis or a drug exposure, or accompanied by scale, erythema, scarring, papules, or other signs of active dermatosis. In these cases, reframe the diagnosis toward post-inflammatory hyperpigmentation, phototoxic dermatitis or phytophotodermatitis, drug-induced pigmentation, lichen planus pigmentosus, erythema dyschromicum perstans, pigmented contact dermatitis, discoid lupus erythematosus, ochronosis, Hori nevus, nevus of Ota, argyria, or macular amyloidosis. PubMedMelasma - StatPearls - NCBI BookshelfPubMedMelasma: A Step-by-Step Approach Towards a Multimodal Combination Therapy

Clinical features that redirect evaluation away from uncomplicated melasma. PubMedMelasma - StatPearls - NCBI BookshelfPubMedEvaluation of Dermoscopic Features in Facial Melanosis with Wood Lamp ExaminationPubMedMelasma: A Step-by-Step Approach Towards a Multimodal Combination Therapy
FindingDiagnostic implicationNext action
Prior inflammatory eruption or procedural injuryPost-inflammatory hyperpigmentation becomes more likely. PubMedMelasma - StatPearls - NCBI BookshelfPubMedMelasma: A Step-by-Step Approach Towards a Multimodal Combination TherapyIdentify and suppress the active inflammatory trigger before intensifying pigment-directed therapy. PubMedMelasma: A Step-by-Step Approach Towards a Multimodal Combination Therapy
Exposure-linked onset after medication, cosmetic, plant, or topical productConsider drug-induced pigmentation, phototoxic dermatitis, phytophotodermatitis, or pigmented contact dermatitis. PubMedMelasma: A Step-by-Step Approach Towards a Multimodal Combination TherapyReview exposures and discontinue the suspected trigger when clinically appropriate. PubMedMelasma: A Step-by-Step Approach Towards a Multimodal Combination Therapy
Blue-gray, curvilinear dermoscopic patternConsider ashy dermatosis or nevus of Ota rather than routine melasma. PubMedEvaluation of Dermoscopic Features in Facial Melanosis with Wood Lamp ExaminationReassess diagnosis; use selective histopathology when the clinical distinction remains uncertain. PubMedMelasma - StatPearls - NCBI Bookshelf
Scale, erythema, scarring, or other active facial lesionsConsider inflammatory dermatoses including discoid lupus erythematosus or lichen planus pigmentosus. PubMedMelasma: A Step-by-Step Approach Towards a Multimodal Combination TherapyEvaluate and treat the primary dermatosis; biopsy selectively if morphology is not diagnostic. PubMedMelasma - StatPearls - NCBI BookshelfPubMedMelasma: A Step-by-Step Approach Towards a Multimodal Combination Therapy

Adjunctive examination

Use dermoscopy selectively; do not let Wood lamp depth determine treatment

Bedside devices can support pattern recognition but should not replace clinical diagnosis.

Dermoscopy can support the diagnosis and characterize pigment and vascular patterns. Reported epidermal-pattern findings include a brown reticuloglobular network; mixed patterns may show patchy brown reticuloglobular pigmentation with gray areas or granules; dermal-pattern descriptions include brown-gray reticuloglobular pigmentation, gray granules, arcuate or honeycomb structures, and perifollicular pigmentation. PubMedComparison of Dermoscope and Woods Lamp as A Tool to Study Melanin Depth in Melasma

Wood lamp may accentuate epidermal pigmentation, but do not use epidermal, dermal, or mixed Wood lamp classification to predict prognosis or select therapy. Findings are inconsistent, particularly in darker phototypes, and Wood lamp evaluation is not suitable for Fitzpatrick skin types V and VI in one comparative study. PubMedMelasma - StatPearls - NCBI BookshelfPubMedComparison of Dermoscope and Woods Lamp as A Tool to Study Melanin Depth in Melasma

Consider reflectance confocal microscopy or other advanced imaging only when available and when a noninvasive diagnostic question remains after examination; reflectance confocal microscopy can demonstrate activated melanocytes, melanophages, and solar elastosis. These techniques do not replace selective biopsy for persistent diagnostic uncertainty or concern for another disorder. PubMedMelasma: A Step-by-Step Approach Towards a Multimodal Combination TherapyPubMedMelasma - StatPearls - NCBI Bookshelf

Practical role of common melasma assessment tools. PubMedMelasma - StatPearls - NCBI BookshelfPubMedA Scoping Review on Melasma Treatments and Their Histopathologic CorrelatesPubMedComparison of Dermoscope and Woods Lamp as A Tool to Study Melanin Depth in Melasma
ToolUseful contributionImportant limitation
Clinical examinationEstablishes the diagnosis, distribution, triggers, and competing differential diagnoses. PubMedMelasma - StatPearls - NCBI BookshelfRequires reassessment when morphology or course is atypical. PubMedMelasma - StatPearls - NCBI BookshelfPubMedMelasma: A Step-by-Step Approach Towards a Multimodal Combination Therapy
DermoscopyCan document reticular, gray granular, and vascular features and assist with facial melanosis differentials. PubMedEvaluation of Dermoscopic Features in Facial Melanosis with Wood Lamp ExaminationPubMedComparison of Dermoscope and Woods Lamp as A Tool to Study Melanin Depth in MelasmaPattern descriptions support but do not independently establish diagnosis. PubMedEvaluation of Dermoscopic Features in Facial Melanosis with Wood Lamp ExaminationPubMedComparison of Dermoscope and Woods Lamp as A Tool to Study Melanin Depth in Melasma
Wood lampMay accentuate epidermal pigment. PubMedMelasma: A Step-by-Step Approach Towards a Multimodal Combination TherapyPubMedComparison of Dermoscope and Woods Lamp as A Tool to Study Melanin Depth in MelasmaDepth classification is inconsistent, should not guide treatment, and is limited in darker skin types. PubMedMelasma - StatPearls - NCBI BookshelfPubMedComparison of Dermoscope and Woods Lamp as A Tool to Study Melanin Depth in Melasma
MASI or modified MASIStandardizes clinical severity tracking across visits and studies. PubMedA Scoping Review on Melasma Treatments and Their Histopathologic CorrelatesDoes not itself identify the cause of facial pigmentation. PubMedA Scoping Review on Melasma Treatments and Their Histopathologic Correlates

First-line management

Control photic and hormonal drivers before escalating pigment-directed therapy

Recurrence is expected when ongoing triggers and barrier injury are not addressed.

Make broad photoprotection a nonnegotiable component of every regimen. Ultraviolet radiation is a major driver of melasma, and visible light can also stimulate pigmentation; therefore, treatment plans should explicitly address both exposures rather than relying on depigmenting medications alone. ScienceDirectBest practices in the treatment of melasma with a focus on patients with skin of color - ScienceDirect

Review whether pregnancy or hormonal contraception temporally correlates with onset or worsening. These associations do not establish that a hormonal therapy must be stopped, but they justify counseling that persistent exposure may complicate pigment control and should be considered alongside contraceptive and reproductive priorities. PubMedMelasma - StatPearls - NCBI BookshelfPubMedMelasma: A Step-by-Step Approach Towards a Multimodal Combination Therapy

Choose a topical regimen that the patient can tolerate consistently. Hydroquinone, retinoids, azelaic acid, and topical tranexamic acid are recognized topical options, but hydroquinone, retinoic acid, and azelaic acid can cause irritation or contact dermatitis. Reduce irritant burden and support the skin barrier if treatment produces inflammation, because inflammation is itself a contributor to hyperpigmentation. NatureMelasma Treatment Strategies in Skin Health | Dermatology | Clinical Sciences | Health sciences | Topics | Nature IndexPubMedThe Application of Skin Care Product in Melasma Treatment - PMC

Set expectations at initiation: melasma is chronic and relapsing, responses vary, and no single modality is uniformly effective. Use serial photographs and MASI or modified MASI rather than premature switching based on day-to-day pigment variation. PubMedMelasma - StatPearls - NCBI BookshelfPubMedA Scoping Review on Melasma Treatments and Their Histopathologic CorrelatesPubMedThe Application of Skin Care Product in Melasma Treatment - PMC

Treatment ladder for melasma, organized by indication and tradeoff. JAMAManaging Facial Hyperpigmentation - JAMA NetworkNatureMelasma Treatment Strategies in Skin Health | Dermatology | Clinical Sciences | Health sciences | Topics | Nature IndexPubMedThe Application of Skin Care Product in Melasma Treatment - PMC
Clinical situationManagement choiceKey tradeoff or action
New or uncomplicated melasmaRigorous ultraviolet and visible-light photoprotection plus topical depigmenting therapy. ScienceDirectBest practices in the treatment of melasma with a focus on patients with skin of color - ScienceDirectNatureMelasma Treatment Strategies in Skin Health | Dermatology | Clinical Sciences | Health sciences | Topics | Nature IndexMonitor for irritation and contact dermatitis from active topicals. PubMedThe Application of Skin Care Product in Melasma Treatment - PMC
Topical intolerance or dermatitisReduce or stop the suspected irritating active and reinforce barrier-supportive skin care. PubMedThe Application of Skin Care Product in Melasma Treatment - PMCTreat inflammation before escalating depigmenting therapy because inflammatory injury can worsen pigment. PubMedThe Application of Skin Care Product in Melasma Treatment - PMCPubMedMelasma: A Step-by-Step Approach Towards a Multimodal Combination Therapy
Persistent severe or refractory diseaseConsider oral tranexamic acid as an adjunct after individualized risk assessment. JAMAManaging Facial Hyperpigmentation - JAMA NetworkCounsel regarding low thrombotic-event risk and relapse after discontinuation. JAMAManaging Facial Hyperpigmentation - JAMA Network
Stable disease seeking adjunctive proceduresConsider superficial chemical peel, laser, phototherapy, or microneedling only as an adjunct to ongoing foundational management. NatureMelasma Treatment Strategies in Skin Health | Dermatology | Clinical Sciences | Health sciences | Topics | Nature IndexWolters KluwerComparative effectiveness of acupuncture, fire... : MedicineBalance potential benefit against procedure-related adverse effects and recurrent disease. NatureMelasma Treatment Strategies in Skin Health | Dermatology | Clinical Sciences | Health sciences | Topics | Nature IndexScienceDirectBest practices in the treatment of melasma with a focus on patients with skin of color - ScienceDirect

Topical treatment selection

For most patients, begin with photoprotection plus a topical depigmenting regimen rather than oral medication or a procedure. Hydroquinone, retinoids, azelaic acid, and topical tranexamic acid are established options in multimodal care; select among them according to prior response and irritation history because tolerability determines whether therapy can be maintained. NatureMelasma Treatment Strategies in Skin Health | Dermatology | Clinical Sciences | Health sciences | Topics | Nature IndexPubMedThe Application of Skin Care Product in Melasma Treatment - PMC

Do not equate stronger irritation with better efficacy. In patients who develop irritant or allergic contact dermatitis, prioritize barrier-supportive skin care and a less irritating regimen before adding another active agent, since topical-treatment adverse effects can perpetuate pigmentary change. PubMedThe Application of Skin Care Product in Melasma Treatment - PMC

Escalation

Reserve oral tranexamic acid and procedures for selected refractory disease

Escalation should follow diagnostic reassessment, trigger control, and optimization of a tolerated topical regimen.

Consider oral tranexamic acid only for severe or refractory melasma as an adjunct to continued photoprotection and topical management. Oral use for melasma is not first-line, and the decision requires individualized assessment of thrombotic risk and counseling that relapse can occur after treatment cessation. JAMAManaging Facial Hyperpigmentation - JAMA NetworkPubMedThe Application of Skin Care Product in Melasma Treatment - PMC

A reported procedural practice uses oral tranexamic acid 325 mg twice daily for 3 months in patients with a history of melasma to prevent rebound or exacerbation around a procedure. This is a procedure-specific approach rather than a universal melasma regimen; use requires the same thrombotic-risk consideration and careful reconciliation of patient-specific contraindications. Wolters KluwerOral Tranexamic Acid for Prevention and Treatment... - OvidJAMAManaging Facial Hyperpigmentation - JAMA Network

Chemical peels, laser and light-based therapies, and microneedling are adjunctive options for stable or treatment-resistant disease, not substitutes for photoprotection and maintenance topical therapy. Because melasma is recalcitrant and recurrent and patients with skin of color may experience treatment-related adverse effects, procedural selection should emphasize conservative technique, informed consent, and close assessment for inflammatory pigment worsening. NatureMelasma Treatment Strategies in Skin Health | Dermatology | Clinical Sciences | Health sciences | Topics | Nature IndexScienceDirectBest practices in the treatment of melasma with a focus on patients with skin of color - ScienceDirectPubMedThe Application of Skin Care Product in Melasma Treatment - PMC

Reassess the diagnosis before repeated procedures or repeated systemic therapy when pigment becomes more gray, asymmetric, inflammatory, or treatment-resistant. A dermal pigment disorder, medication-associated pigmentation, contact dermatitis, or steroid-related facial dermatitis can produce an apparent treatment failure that will not be corrected by simply increasing pigment-directed treatment intensity. PubMedMelasma - StatPearls - NCBI BookshelfPubMedEvaluation of Dermoscopic Features in Facial Melanosis with Wood Lamp ExaminationPubMedMelasma: A Step-by-Step Approach Towards a Multimodal Combination Therapy

Escalation decisions in refractory melasma. JAMAManaging Facial Hyperpigmentation - JAMA NetworkNatureMelasma Treatment Strategies in Skin Health | Dermatology | Clinical Sciences | Health sciences | Topics | Nature IndexScienceDirectBest practices in the treatment of melasma with a focus on patients with skin of color - ScienceDirectWolters KluwerOral Tranexamic Acid for Prevention and Treatment... - Ovid
OptionWhen to considerDecision-limiting issue
Oral tranexamic acidSevere or refractory melasma after foundational management has been optimized. JAMAManaging Facial Hyperpigmentation - JAMA NetworkAssess thrombotic risk; counsel on low thrombotic-event risk and relapse after discontinuation. JAMAManaging Facial Hyperpigmentation - JAMA Network
Oral tranexamic acid around a procedureA reported practice is 325 mg twice daily for 3 months in patients with melasma history to prevent rebound or exacerbation. Wolters KluwerOral Tranexamic Acid for Prevention and Treatment... - OvidThis is procedure-context use and requires individualized safety assessment. Wolters KluwerOral Tranexamic Acid for Prevention and Treatment... - OvidJAMAManaging Facial Hyperpigmentation - JAMA Network
Chemical peelAdjunctive treatment for stable disease within multimodal care. NatureMelasma Treatment Strategies in Skin Health | Dermatology | Clinical Sciences | Health sciences | Topics | Nature IndexWolters KluwerComparative effectiveness of acupuncture, fire... : MedicineProcedure-induced injury can complicate management of pigmentary disease; continue photoprotection. NatureMelasma Treatment Strategies in Skin Health | Dermatology | Clinical Sciences | Health sciences | Topics | Nature IndexScienceDirectBest practices in the treatment of melasma with a focus on patients with skin of color - ScienceDirect
Laser or light-based therapyAdjunctive option after counseling in selected patients with persistent disease. NatureMelasma Treatment Strategies in Skin Health | Dermatology | Clinical Sciences | Health sciences | Topics | Nature IndexWolters KluwerComparative effectiveness of acupuncture, fire... : MedicineRecurrence and adverse effects require conservative patient selection, particularly in skin of color. ScienceDirectBest practices in the treatment of melasma with a focus on patients with skin of color - ScienceDirect
MicroneedlingAdjunctive modality, including approaches intended to enhance topical delivery. NatureMelasma Treatment Strategies in Skin Health | Dermatology | Clinical Sciences | Health sciences | Topics | Nature IndexWolters KluwerImproved clinical efficacy of melasma with combination... : MedicineDo not use it as a replacement for diagnosis, trigger control, and maintenance therapy. NatureMelasma Treatment Strategies in Skin Health | Dermatology | Clinical Sciences | Health sciences | Topics | Nature IndexScienceDirectBest practices in the treatment of melasma with a focus on patients with skin of color - ScienceDirect

Monitoring

Monitor for recurrence, treatment injury, and diagnostic drift

Follow-up should measure both pigment response and treatment-induced inflammation.

At each follow-up, compare standardized photographs and a consistent MASI or modified MASI score with baseline, then ask specifically about pruritus, burning, erythema, scale, new acneiform or rosacea-like change, and treatment adherence. A worsening inflammatory examination should trigger regimen simplification and reassessment for contact dermatitis or another diagnosis rather than automatic escalation. PubMedA Scoping Review on Melasma Treatments and Their Histopathologic CorrelatesPubMedThe Application of Skin Care Product in Melasma Treatment - PMCPubMedEvaluation of Dermoscopic Features in Facial Melanosis with Wood Lamp Examination

When pigment improves, continue trigger control and maintenance-oriented skin care because recurrence is characteristic and photic exposure remains a continuing stimulus. Topical skin care support may reduce adverse effects and can be incorporated into maintenance strategies. PubMedThe Application of Skin Care Product in Melasma Treatment - PMCScienceDirectBest practices in the treatment of melasma with a focus on patients with skin of color - ScienceDirect

Reassess quality-of-life burden with MELASQoL when clinical severity and patient distress diverge. Visible facial pigment may have substantial psychosocial consequences, and patient-reported burden can appropriately influence the choice to intensify, simplify, or defer treatment. PubMedMelasma - StatPearls - NCBI BookshelfPubMedA Scoping Review on Melasma Treatments and Their Histopathologic Correlates

Follow-up findings and the next management decision. PubMedMelasma - StatPearls - NCBI BookshelfPubMedA Scoping Review on Melasma Treatments and Their Histopathologic CorrelatesPubMedThe Application of Skin Care Product in Melasma Treatment - PMC
Follow-up findingInterpretationNext step
Improved MASI or modified MASI without inflammationClinical response is occurring. PubMedA Scoping Review on Melasma Treatments and Their Histopathologic CorrelatesContinue effective photoprotection and tolerated maintenance treatment. ScienceDirectBest practices in the treatment of melasma with a focus on patients with skin of color - ScienceDirectPubMedThe Application of Skin Care Product in Melasma Treatment - PMC
Burning, erythema, scale, or eczematous eruptionPossible irritant or allergic contact dermatitis from topical therapy. PubMedThe Application of Skin Care Product in Melasma Treatment - PMCSimplify or stop the suspected topical active and address barrier injury before escalation. PubMedThe Application of Skin Care Product in Melasma Treatment - PMC
Relapse after improvementConsistent with chronic, recurrent melasma and ongoing trigger exposure. PubMedMelasma - StatPearls - NCBI BookshelfPubMedThe Application of Skin Care Product in Melasma Treatment - PMCReview photic, hormonal, product, and adherence factors; restart or optimize tolerated foundational therapy. ScienceDirectBest practices in the treatment of melasma with a focus on patients with skin of color - ScienceDirectPubMedMelasma: A Step-by-Step Approach Towards a Multimodal Combination Therapy
Morphologic change or lack of response despite optimized carePossible alternative diagnosis or coexisting inflammatory disorder. PubMedMelasma - StatPearls - NCBI BookshelfPubMedMelasma: A Step-by-Step Approach Towards a Multimodal Combination TherapyRepeat focused examination, use dermoscopy as appropriate, and consider selective biopsy. PubMedMelasma - StatPearls - NCBI BookshelfPubMedEvaluation of Dermoscopic Features in Facial Melanosis with Wood Lamp Examination

References

  1. Managing Facial Hyperpigmentation - JAMA Networkjamanetwork.com · jamanetwork.com
  2. Safety and efficacy of niosomal and conventional tranexamic acid/niacinamide vs. hydroquinone creams in melasma: A randomized, double-blind, case-controlled clinical trial | Scientific Reportswww.nature.com · www.nature.com
  3. Melasma Treatment Strategies in Skin Health | Dermatology | Clinical Sciences | Health sciences | Topics | Nature Indexwww.nature.com · www.nature.com
  4. CONSORT 2010 Statement: Updated Guidelines for Reporting ...annals.org · annals.org
  5. Preferred Reporting Items for Systematic Reviews and Meta-Analysesannals.org · annals.org
  6. Comparative effectiveness of acupuncture, fire... : Medicinejournals.lww.com · journals.lww.com
  7. Evaluating the robustness of the international... : Journal of the European Academy of Dermatology & Venereologyjournals.lww.com · journals.lww.com
  8. Assessing the Safety and Efficacy of Picosecond Alexandrite Lasers ...journals.lww.com · journals.lww.com
  9. Abstracts : Itch - Ovidjournals.lww.com · journals.lww.com
  10. Best practices in the treatment of melasma with a focus on patients with skin of color - ScienceDirectwww.sciencedirect.com · www.sciencedirect.com
  11. Efficacy and safety of adjuvant topical application of botanicals in the treatment of melasma: A systematic review and meta-analysis - ScienceDirectwww.sciencedirect.com · www.sciencedirect.com
  12. Melasma - StatPearls - NCBI Bookshelfwww.ncbi.nlm.nih.gov · www.ncbi.nlm.nih.gov
  13. Evaluation of Dermoscopic Features in Facial Melanosis with Wood Lamp Examinationpmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
  14. Quantitative classification of melasma with photoacoustic microscopy: a pilot study - PMCpmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
  15. A Scoping Review on Melasma Treatments and Their Histopathologic Correlatespmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
  16. Melasma: A Step-by-Step Approach Towards a Multimodal Combination Therapypmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
  17. Comparison of Dermoscope and Woods Lamp as A Tool to ...pubmed.ncbi.nlm.nih.gov · pubmed.ncbi.nlm.nih.gov
  18. Wood's Light - StatPearls - NCBI Bookshelfwww.ncbi.nlm.nih.gov · www.ncbi.nlm.nih.gov
  19. The Application of Skin Care Product in Melasma Treatment - PMCwww.ncbi.nlm.nih.gov · www.ncbi.nlm.nih.gov
  20. Dermatology World Weeklywww.aad.org · www.aad.org
  21. Microneedling combined with irradiated human amniotic gel versus ...journals.lww.com · journals.lww.com
  22. Oral Tranexamic Acid for Prevention and Treatment... - Ovidjournals.lww.com · journals.lww.com
  23. Improved clinical efficacy of melasma with combination... : Medicinejournals.lww.com · journals.lww.com
  24. Comparison of Dermoscope and Woods Lamp as A Tool to Study Melanin Depth in Melasmapmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov